Pegdinetanib (BMS-844203) is a Selective VEGFR-2 Inhibitor
Pegdinetanib (BMS-844203), an anti-angiogenic therapeutic agent, exemplifies a new class of targeted biologics called Adnectins. Adnectins are genetically engineered variants of the tenth type III domain of human fibronectin. Firstly,…